Israel provides advanced breast cancer care beyond standard surgery, including targeted therapies like HER2 inhibitors, immunotherapy for triple-negative cases, and intraoperative radiation. Leading centers offer genomic profiling, liquid biopsies, and organ-preserving techniques like cryoablation to maintain tissue while effectively neutralizing tumors.
- Radiation options: Intrabeam intraoperative therapy delivers localized radiation during surgery, potentially eliminating weeks of treatment.
- Biological therapy: Targeted drugs like Enhertu and Kadcyla treat HER2-positive cases with fewer systemic side effects.
- Genomic testing: Oncotype DX and Foundation One CDx tests help avoid unnecessary chemotherapy for patients.
- Innovative surgery: Surgeons like Dr. Dov Zippel specialize in organ-preserving lumpectomy and minimally invasive approaches.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center treat 40,000 cancer patients annually, creating a massive data pool for personalized care. While many seek surgery, the real advantage is access to the Israeli National Genomic Medicine Initiative led by experts like Dr. Ari Raphael. This program allows for liquid biopsies that catch recurrence much earlier than traditional scans.
Patient Consensus: Patients value how coordinators help navigate pitfalls in complex treatment schedules. Many emphasize inquiring about chemo-free protocols and cryoablation during initial consultations for breast lesions.